NAD + in aging, metabolism, and neurodegeneration
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Nicotinamide adenine dinucleotide (NAD + ) is a coenzyme found in all living cells. It serves both as a critical coenzyme for enzymes that fuel reduction-oxidation reactions, carrying electrons from one reaction to another, and as a cosubstrate for other enzymes such as the sirtuins and poly(adenosine diphosphate–ribose) polymerases. Cellular NAD + concentrations change during aging, and modulation of NAD + usage or production can prolong both health span and life span. Here we review factors that regulate NAD + and discuss how supplementation with NAD + precursors may represent a new therapeutic opportunity for aging and its associated disorders, particularly neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, the total NAD+ + NADH pool was smaller in the apoE4 cells, suggesting that apoE4 impairs NAD+ synthetic capacity [68].”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [68]
In the citing paper
“Nicotinamide phosphoribosyl transferase (NAMPT) catalyzes the rate limiting step in the NAD salvage pathway from nicotinamide (NAM) (Garten et al., 2015; Verdin, 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Verdin, 2015
In the citing paper
“Persistently activated PARP1, however, consumes large amounts of NAD+, an essential coenzyme of sirtuins (SIRTs) (69).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [69]
In the citing paper
“restoration of NAD levels with the NAD precursor vitamins nicotinamide riboside (NR), nicotinamide (NAM) and nicotinic acid (NA), in addition to the biosynthetic NAD precursor nicotinamide mononucleotide (NMN), appears to mitigate several age-associated diseases2-4.”
From Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages (2020) · cites this paper as [4]
In the citing paper
“The NAD+ salvage pathway starts from the recycling of nicotinamide (NAM) to nicotinamide mononucleotide (NMN) by intracellular nicotinamide phosphoribosyltransferase (iNAMPT), followed by the conversion of NMN into NAD+ via the NMNATs (Bogan and Brenner, 2008; Verdin, 2015).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Verdin, 2015
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats
Braidy, N., Guillemin, G. J., Mansour, H., Chan-Ling, T., Poljak, A., & Grant, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019194 · Cited by 594
RetractedLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Cited by
Items 101–200 of 1,000
ADP ‐ribosylation: new facets of an ancient modification
Palazzo, L., Mikoč, A., & Ahel, I. (2017) · FEBS Journal · doi:10.1111/febs.14078 · Cited by 155
“45 Verdin E (2015) NAD+ in aging, metabolism, and neurodegeneration.”
BackgroundSadria, M., & Layton, A. T. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00706-1 · Cited by 154
“The major source of NAD+ in mammals is the salvage pathway, which recycles NAM produced by enzymes utilizing NAD+ (22).”
BackgroundCD38 in Neurodegeneration and Neuroinflammation
Guerreiro, S., Privat, A.-L., Bressac, L., & Toulorge, D. (2020) · Cells · doi:10.3390/cells9020471 · Cited by 141
Kim, D.-S., Challa, S., Jones, A., & Kraus, W. L. (2020) · Genes & Development · doi:10.1101/gad.334433.119 · Cited by 160
“While nutritional supplements such as Vitamin B3 act as dietary precursors for NAD+ biosynthesis, intracellular salvage pathways using nicotinamide (NAM) are the primary source of NAD+ in the cell (Verdin 2015).”
BackgroundZhang, H., Zhao, Y., & Zhou, D.-X. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx825 · Cited by 139
Kirkland, J. B., & Meyer‐Ficca, M. L. (2018) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2017.11.003 · Cited by 165
Chini, C., Hogan, K. A., Warner, G. M., Tarragó, M. G., Peclat, T. R., Tchkonia, T., Kirkland, J. L., & Chini, E. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.199 · Cited by 138
Huang, Y., Zhao, M., Chen, X., Zhang, R., Le, A., Hong, M., Zhang, Y., Jia, L., Zang, W., Jiang, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0916 · Cited by 138
Aaldijk, E., & Vermeiren, Y. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101556 · Cited by 141
“Nicotinamide adenine dinucleotide (NAD+), which is an essential cofactor important for mitochondrial function, gained interest as a possible modulator of age-related diseases (for review: Castro-Portuguez and Sutphin, 2020; Verdin, 2015).”
BackgroundSemisynthetic biosensors for mapping cellular concentrations of nicotinamide adenine dinucleotides
Sallin, O., Reymond, L., Gondrand, C., Raith, F., Koch, B., & Johnsson, K. (2018) · eLife · doi:10.7554/elife.32638 · Cited by 134
“NAD+ is also a cofactor for sirtuins and poly(ADP-ribose) polymerases (PARPs), enzymes which regulate numerous important cellular functions (Cantó et al., 2015; Verdin, 2015; Peek et al., 2013).”
InfluentialPreclinical and clinical evidence of NAD+ precursors in health, disease, and ageing
Reiten, O. K., Wilvang, M. A., Mitchell, S. J., Hu, Z., & Fang, E. F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111567 · Cited by 133
“Whereas SIRT1, SIRT6 and SIRT7 are mainly located in the nucleus, SIRT2 is cytoplasmic and SIRT3− 5 are mitochondrial (Chalkiadaki and Guarente, 2015; Verdin, 2015b).”
BackgroundInfluentialRegulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson’s disease
Shen, Y., Wu, Q., Shi, J., & Zhou, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110928 · Cited by 146
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Sonntag, K.-C., Ryu, W.-I., Amirault, K. M., Healy, R. A., Siegel, A. J., McPhie, D. L., Forester, B., & Cohen, B. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14420-x · Cited by 131
Toker, L., Tran, G. T., Sundaresan, J., Tysnes, O., Alves, G. W., Haugarvoll, K., Nido, G. S., Dölle, C., & Tzoulis, C. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00450-7 · Cited by 137
“We were specifically interested in these proteins, because they have been linked to aging and neurodegeneration [41].”
BackgroundMitochondrial complex I as a therapeutic target for Alzheimer's disease
Trushina, E. V., Trushin, S., & Hasan, M. F. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.003 · Cited by 141
A genetically encoded tool for manipulation of NADP+/NADPH in living cells
Cracan, V., Titov, D. V., Shen, H., Grabarek, Z., & Mootha, V. K. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2454 · Cited by 129
Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
Jha, S. K., Rubis, G. D., Devkota, S. R., Zhang, Y., Adhikari, R., Jha, L. A., Bhattacharya, K., Mehndiratta, S., Gupta, G., Singh, S. K., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102315 · Cited by 151
“Additionally, medications that stimulate NAD-dependent sirtuin enzymes and restore the metabolic signaling molecule NAD are being researched (Tarrago et al., 2018; Verdin, 2015; Woo et al., 2019; Yoshino et al., 2018).”
Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Harder, J. M., Guymer, C., Wood, J. P. M., Daskalaki, E., Chidlow, G., Zhang, C., Balasubramanian, R., Cardozo, B. H., Foxworth, N. E., Deering, K. E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014213117 · Cited by 127
“One is a pyruvate-induced increase in NAD availability to NAD-consuming enzymes that generate NAM (e.g., PARPs and SIRTs; although pyruvate doesn ’ t directly produce NAD in these reactions) (26, 27).”
PhotoAgeClock: deep learning algorithms for development of non-invasive visual biomarkers of aging
Bobrov, E., Georgievskaya, A., Kiselev, K., Sevastopolsky, A., Zhavoronkov, A., Gurov, S., Rudakov, K., del Pilar Bonilla Tobar, M., Jaspers, S., & Clemann, S. (2018) · Aging · doi:10.18632/aging.101629 · Cited by 125
Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease
Lee, C. F., Caudal, A., Abell, L., Gowda, G. A. N., & Tian, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-39419-4 · Cited by 134
Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders
Dakroub, A. H., Nasser, S. A., Younis, N. K., Bhagani, H., Al-Dhaheri, Y., Pintus, G., Eid, A. A., EL‐Yazbi, A. F., & Eid, A. H. (2020) · Cells · doi:10.3390/cells9112444 · Cited by 134
“Several AD+ dependent cellular signaling pathways exist and involve sirtuins, CD38/CD157, and P RPs/ RTs.”
BackgroundInfluentialRyu, W.-I., Bormann, M. K., Shen, M., Kim, D., Forester, B., Park, Y., So, J., Seo, H., Sonntag, K.-C., & Cohen, B. M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01068-3 · Cited by 125
“NAD levels and biochemical factors in its synthesis and/or recycling pathway diminish with age or in neurodegenerative diseases, including LOAD [28, 30, 31].”
BackgroundThe Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update
Song, Q., Zhou, X., Xu, K., Liu, S., Zhu, X., & Yang, J. J. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.008 · Cited by 139
Wang, Y., Wang, F., Wang, L., Qiu, S., Yao, Y., Yan, C., Xiong, X., Chen, X., Ji, Q., Cao, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109516 · Cited by 121
Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import
Girardi, E., Agrimi, G., Goldmann, U., Fiume, G., Lindinger, S., Sedlyarov, V., Srndic, I., Gürtl, B., Agerer, B., Kartnig, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19871-x · Cited by 123
Wallrabe, H. K., Švindrych, Z., Alam, S. R., Siller, K. H., Wang, T., Kashatus, D. F., Hu, S., & Periasamy, A. (2018) · Scientific Reports · doi:10.1038/s41598-017-18634-x · Cited by 121
Sun, X., Cao, B., Naval-Sanchez, M., Pham, T., Sun, Y. B. Y., Williams, B., Heazlewood, S. Y., Deshpande, N., Li, J., Kraus, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22863-0 · Cited by 119
Buang, N., Tapeng, L., Gray, V., Sardini, A., Whilding, C., Lightstone, L., Cairns, T. D., Pickering, M. C., Behmoaras, J., Ling, G. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22312-y · Cited by 118
Cellular senescence, DNA damage, and neuroinflammation in the aging brain
Zhang, W., Sun, H.-S., Wang, X., Dumont, A. S., & Liu, Q. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.04.003 · Cited by 104
Zou, Y., Wang, A., Huang, L., Zhu, X., Hu, Q., Zhang, Y., Chen, X., Li, F., Wang, Q., Wang, H., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.02.017 · Cited by 115
Therapeutic application of natural products: NAD+ metabolism as potential target
Guo, C., Huang, Q., Wang, Y., Yao, Y., Li, J., Chen, J., Wu, M., Zhang, Z., Mingyao, E., Qi, H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154768 · Cited by 127
The chemistry of the vitamin B3 metabolome
Makarov, M. V., Trammell, S. A. J., & Migaud, M. E. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180420 · Cited by 120
Li, B., Xin, Z., Gao, S., Li, Y., Guo, S., Fu, Y., Zhang, P., Wang, D., Cheng, J., Liu, L., et al. (2022) · Theranostics · doi:10.7150/thno.78878 · Cited by 120
“critical factor for the pathogenesis of various diabetes-related diseases [41].”
Dihydronicotinamide riboside is a potent NAD+ concentration enhancer in vitro and in vivo
Yang, Y., Mohammed, F. S., Zhang, N., & Sauve, A. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005772 · Cited by 109
NAD+ flux is maintained in aged mice despite lower tissue concentrations
McReynolds, M. R., Chellappa, K., Chiles, E., Jankowski, C., Shen, Y., Chen, L., Descamps, H. C., Mukherjee, S., Bhat, Y. R., Lingala, S. R., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.09.001 · Cited by 112
Nicotinamide Deficiency in Primary Open-Angle Glaucoma
Kouassi Nzoughet, J., Chao de la Barca, J. M., Guehlouz, K., Leruez, S., Coulbault, L., Allouche, S., Bocca, C., Muller, J., Amati-Bonneau, P., Gohier, P., et al. (2019) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.19-27099 · Cited by 110
The taming of PARP1 and its impact on NAD+ metabolism
Hurtado-Bagès, S., Knobloch, G., Ladurner, A. G., & Buschbeck, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.014 · Cited by 130
“Importantly, the NMNATs of all cell compartments compete for the same pool of NMN produced by NAMPT thereby placing the intermediate in a central position of linking NADþ metabolism of different compartments.”
BackgroundInfluentialInterplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family
Cohen, M. S. (2020) · Genes & Development · doi:10.1101/gad.335109.119 · Cited by 107
“1; Verdin 2015).”
HDAC11 suppresses the thermogenic program of adipose tissue via BRD2
Bagchi, R. A., Ferguson, B. S., Stratton, M. S., Hu, T., Cavasin, M. A., Sun, L., Lin, Y.-H., Liu, D., Londono, P., Song, K., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120159 · Cited by 110
NMN Maintains Intestinal Homeostasis by Regulating the Gut Microbiota
Huang, P., Jiang, A., Wang, X., Zhou, Y., Tang, W., Ren, C., Qian, X., Zhou, Z., & Gong, A. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.714604 · Cited by 110
Emergent Biosensing Technologies Based on Fluorescence Spectroscopy and Surface Plasmon Resonance
Camarca, A., Varriale, A., Capo, A., Pennacchio, A., Calabrese, A., Giannattasio, C., Almuzara, C. M., D’Auria, S., & Staiano, M. (2021) · Sensors · doi:10.3390/s21030906 · Cited by 115
“Its levels are often altered in aging, neurodegeneration, kidney injury, obesity, diabetes, adipogenesis, cancer, and congenital malformations [202,203].”
BackgroundSirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein
Watanabe, H., Inaba, Y., Kimura, K., Matsumoto, M., Kaneko, S., Kasuga, M., & Inoue, H. (2018) · Nature Communications · doi:10.1038/s41467-017-02537-6 · Cited by 113
Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation
Hopp, A.-K., Grüter, P., & Hottiger, M. O. (2019) · Cells · doi:10.3390/cells8080890 · Cited by 114
“A detailed overview of the NAD+ metabolic pathways has been extensively described in other reviews [1,25,29,30].”
BackgroundMetabolism and the Epigenome: A Dynamic Relationship
Haws, S. A., Leech, C. M., & Denu, J. M. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.04.002 · Cited by 115
Tryptophan and its metabolites in normal physiology and cancer etiology
Perez‐Castro, L., Garcia, R., Venkateswaran, N., Barnes, S. D., & Conacci‐Sorrell, M. (2021) · FEBS Journal · doi:10.1111/febs.16245 · Cited by 122
Sending Out an SOS: Mitochondria as a Signaling Hub
Bohovych, I., & Khalimonchuk, O. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00109 · Cited by 103
“…of various cellular activities such as histone modification and modulation of master transcriptional regulators like forkhead box 03 (FOXO3), nuclear factor kappa B (NF-κB), and peroxisome proliferatoractivated receptor gamma co-activator 1 alpha (PGC-1α, Canto et al., 2015; Verdin, 2015).”
BackgroundDolopikou, C. F., Kourtzidis, I. A., Margaritelis, N. V., Vrabas, I. S., Koidou, E., Kyparos, A., Theodorou, A. A., Paschalis, V., & Nikolaidis, M. G. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01919-4 · Cited by 114
Regulation of NAD+ metabolism in aging and disease
Chu, X., & Raju, R. P. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154923 · Cited by 115
Mitochondria–Power Players in Kidney Function?
Forbes, J. M. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.05.002 · Cited by 106
“An elegant study in the journal Nature has highlighted the intimate relationship between cellular maintenance of the mitochondrial fuel precursor NAD/NADH [1], mitochondrial health, and kidney function [2].”
BackgroundTargeting glutamine metabolism slows soft tissue sarcoma growth
Lee, P., Malik, D. M., Perkons, N. R., Huangyang, P., Khare, S., Rhoades, S. D., Gong, Y.-Y., Burrows, M., Finan, J. M., Nissim, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14374-1 · Cited by 109
Tammaro, A., Kers, J., Scantlebery, A. M. L., & Florquin, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01346 · Cited by 112
“Hypoxia and aging (74, 75) have been known to induce NAD-consuming enzymes, which lowers NAD availability.”
BackgroundOrr, A. L., Kim, C., Jimenez-Morales, D., Newton, B. W., Johnson, J. R., Krogan, N. J., Swaney, D. L., & Mahley, R. W. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181184 · Cited by 103
“Interestingly, the total NAD+ + NADH pool was smaller in the apoE4 cells, suggesting that apoE4 impairs NAD+ synthetic capacity [68].”
BackgroundAddressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
Ghanem, G. O. B., Wareham, L. K., & Calkins, D. J. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101261 · Cited by 112
“NAD + serves as a critical coenzyme in redox reactions and acts as an energy transfer intermediate and cosubstrate for other non-redox enzymes (Verdin, 2015).”
BackgroundGlaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
Williams, P. A., Harder, J. M., & John, S. W. M. (2017) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000767 · Cited by 102
Yang, L., Shen, J., Liu, C., Kuang, Z., Tang, Y., Qian, Z., Guan, M., Yang, Y., Zhan, Y., Li, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36543-8 · Cited by 110
Spatial transcriptomic clocks reveal cell proximity effects in brain ageing
Sun, E., Zhou, O. Y., Hauptschein, M., Rappoport, N., Xu, L., Negredo, P. N., Liu, L. A., Rando, T. A., Zou, J., & Brunet, A. (2024) · Nature · doi:10.1038/s41586-024-08334-8 · Cited by 131
Hepatic senescence, the good and the bad
Huda, N., Liu, G., Hong, H., Yan, S., Khambu, B., & Yin, X.-M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5069 · Cited by 100
Epigenetic regulation of energy metabolism in obesity
Gao, W., Liu, J.-L., Lu, X., & Yang, Q. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab043 · Cited by 92
“Sirt 1 may also modify histone acetylation such as H 3 K 9 ac and H 4 K 16 ac to regulate target gene expression (Canto et al., 2015 ; Verdin, 2015 ; Ryu et al., 2018 ).”
Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3‐dependent mechanism in male mice
Klimova, N., Long, A., & Kristián, T. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24397 · Cited by 100
“NAD+ levels decrease in brain with age, in obesity or diabetes (Imai & Guarente, 2014; Verdin, 2015; Yoshino, Mills, Yoon, & Imai, 2011), under pathologic conditions of neurodegenerative disease (Liu et al., 2013; Long et al., 2015; Lu et al., 2014; Martire, Mosca, & d’Erme, 2015), and also…”
BackgroundPharmacological restoration of autophagy reduces hypertension-related stroke occurrence
Forte, M., Bianchi, F., Cotugno, M., Marchitti, S., FALCO, E. D., Raffa, S., Stanzione, R., Nonno, F. D., Chimenti, I., Palmerio, S., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1687215 · Cited by 101
Targeting acute kidney injury in COVID-19
Kellum, J. A., van Till, J. W. O., & Mulligan, G. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa231 · Cited by 107
Vascular endothelium in diabetes
Goligorsky, M. S. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00473.2016 · Cited by 104
Miyamoto, S. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0286-9 · Cited by 105
Mitochondrial Metabolism in Acute Kidney Injury
Clark, A. J., & Parikh, S. M. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.01.002 · Cited by 99
Ravula, A. R., Teegala, S. B., Kalakotla, S., Pasangulapati, J. P., Perumal, V., & Boyina, H. K. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174492 · Cited by 98
Nicotinamide treatment robustly protects from inherited mouse glaucoma
Williams, P. A., Harder, J. M., Cardozo, B. H., Foxworth, N. E., & John, S. W. M. (2018) · Communicative & Integrative Biology · doi:10.1080/19420889.2017.1356956 · Cited by 96
“Declining NAD is appearing as a shared mechanism in aging and neurodegeneration.(15,16) As such an important avenue in future research will be to test”
BackgroundNutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS
Xin, L., İpek, Ö., Beaumont, M., Shevlyakova, M., Christinat, N., Masoodi, M., Greenberg, N., Rolf Gruetter, A., & Cuenoud, B. M. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00062 · Cited by 106
“A decline in NAD availability and abnormal NAD/NADH redox state has been directly linked to age-related metabolic diseases and neurodegenerative disorders (10).”
BackgroundZhang, H., Li, J., Chen, Y., Wu, J., Wang, K., Chen, L., Wang, Y., Jiang, X., Liu, Y., Wu, Y., et al. (2021) · Advanced Materials · doi:10.1002/adma.202100472 · Cited by 96
Axonal energy metabolism, and the effects in aging and neurodegenerative diseases
Yang, S., Park, J. H., & Lu, H.-C. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00634-3 · Cited by 94
Circadian blueprint of metabolic pathways in the brain
Greco, C. M., & Sassone–Corsi, P. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0096-y · Cited by 93
Mitochondrial Dysfunction in Neurodegenerative Diseases
Yang, H. (2025) · Cells · doi:10.3390/cells14040276 · Cited by 103
“Recently, boosting nicotinamide adenine dinucleotide + (NAD + ) levels through nicotinamide riboside or nicotinamide mononucleotide has gained traction for supporting cellular metabolism in models of AD, PD, and HD [138].”
Macroautophagy and aging: The impact of cellular recycling on health and longevity
Nieto-Torres, J. L., & Hansen, M. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101020 · Cited by 99
Wang, X., Zhang, Q., Bao, R., Zhang, N., Wang, Y., Polo‐Parada, L., Tarim, A. O., Alemifar, A., Han, X., Wilkins, H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.022 · Cited by 93
“In addition to facilitating redox reactions, NAD+ is also a co-substrate of several important NAD+consuming enzymes, including sirtuins (SIRTs), poly(ADP-ribose) polymerases (PARPs), and CD38 (Cantó et al., 2015; Verdin, 2015).”
BackgroundMoutinho, M., Puntambekar, S. S., Tsai, A. P., Coronel, I., Lin, P. B., Casali, B. T., Martinez, P., Oblak, A. L., Lasagna-Reeves, C. A., Lamb, B. T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl7634 · Cited by 92
Who watches the watchmen? Regulation of the expression and activity of sirtuins
Buler, M., Andersson, U., & Hakkola, J. (2016) · The FASEB Journal · doi:10.1096/fj.201600410rr · Cited by 84
Therapeutic potential of boosting NAD+ in aging and age-related diseases
Aman, Y., Qiu, Y., Tao, J., & Fang, E. F. (2018) · Translational Medicine of Aging · doi:10.1016/j.tma.2018.08.003 · Cited by 82
Axon injury signaling and compartmentalized injury response in glaucoma
Syc‐Mazurek, S. B., & Libby, R. T. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.002 · Cited by 99
“Levels of NAD+ and its reduced form NADH decrease during the aging process and thus augmenting NAD+ levels might serve as protective for age-associated neurodegenerative conditions (Verdin, 2015; Williams et al., 2017b).”
BackgroundThe role of the ATP-adenosine axis in ischemic stroke
Schädlich, I. S., Winzer, R., Stabernack, J., Tolosa, E., Magnus, T. U., & Rissiek, B. (2023) · Seminars in Immunopathology · doi:10.1007/s00281-023-00987-3 · Cited by 96
Salech, F., Ponce, D. P., Paula-Lima, A. C., SanMartín, C. D., & Behrens, M. I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00255 · Cited by 99
“During the aging process the levels of NAD+ decline and agents that elevate intracellular NAD+ have shown promising results against neurodegeneration and aging (Verdin, 2015; Braidy et al., 2019; Hou et al., 2019).”
BackgroundTargeting metabolic pathways for extension of lifespan and healthspan across multiple species
Parkhitko, A. A., Filine, E., Mohr, S. E., Moskalev, A., & Perrimon, N. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101188 · Cited by 94
“Thus, mammals use the salvage pathway to recycle NAD+ from nicotinamide (NAM) (Canto et al., 2015; Castro-Portuguez and Sutphin, 2020; Lautrup et al., 2019; Verdin, 2015).”
BackgroundMethodExtracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity
Wilk, A., Hayat, F., Cunningham, R., Li, J., Garavaglia, S., Zamani, L., Ferraris, D. M., Sykora, P., Andrews, J., Clark, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57506-9 · Cited by 87
Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease
Dornas, W., & Schuppan, D. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00121.2020 · Cited by 97
“mised, by supporting the maintenance of cellular redox homeostasis via regulation of the biosynthesis, utilization, and regeneration of glutathione and a favorable NAD -to-NADPH ratio, to control ROS generation (46, 112).”
BackgroundFunctional microbiome deficits associated with ageing: Chronological age threshold
Ruiz‐Ruiz, S., Sanchez‐Carrillo, S., Ciordia, S., Mena, M. C., Méndez‐García, C., Rojo, D., Bargiela, R., Zubeldia‐Varela, E., Martínez‐Martínez, M., Barbas, C., et al. (2020) · Aging Cell · doi:10.1111/acel.13063 · Cited by 89
“The depletion of both NAD+ and NAM in human cells is detected in individuals with major neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, cardiovascular disease, muscle atrophy and cancer (Verdin 2015; Roager & Licht, 2018; Fang, 2019; Platten et al., 2019).”
BackgroundCD38: An important regulator of T cell function
Li, W., Liang, L., Liao, Q., Li, Y., & Zhou, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113395 · Cited by 98
Perspectives on the interactions between metabolism, redox, and epigenetics in plants
Shen, Y., Issakidis‐Bourguet, E., & Zhou, D. (2016) · Journal of Experimental Botany · doi:10.1093/jxb/erw310 · Cited by 92
“Considerable attention has been paid to the hypothetical role of fluctuating NAD+ levels as a function of energetic status and the activity of sirtuins in mammalian and yeast cells (Canto and Auwerx, 2011; Guarente, 2011; Verdin, 2015).”
BackgroundQin, K., Han, C., Zhang, H., Li, T., Li, N., & Cao, X. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.04.006 · Cited by 92
Wu, B., Feng, J., Yu, L., Wang, Y., Chen, Y., Wei, Y., Han, J., Xiao, F., Zhang, Y., Di, S., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14457 · Cited by 93
“Because it possesses a polyphenolic structure similar to resveratrol, icariin may activate SIRT1 through similar mechanisms (Canto et al., 2009; Park et al., 2012; Verdin, 2015).”
BackgroundXu, Y., Huang, A., Yi, W., Chen, G., Huang, S., & Chen, G. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215517 · Cited by 91
Dayton, T. L., Alcala, N., Moonen, L., den Hartigh, L., Geurts, V., Mangiante, L., Lap, L. M. V., Dost, A. F. M., Beumer, J., Levy, S., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.11.007 · Cited by 93
“…of other tumor types (colorectal cancer and pancreatic ductal adenocarcinoma), and healthy intestinal tissue organoids to FK866, an inhibitor of nicotinamide phos-phoribosyltransferase (NAMPT), the enzyme that catalyzes the rate-limiting step in the NAD+ salvage pathway 65 (Figures 6E– 6F and S6G).”
Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review
Carrera‐Juliá, S., Moreno, M. L., Barrios, C., Ortí, J. E. D. L. R., & Drehmer, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00063 · Cited by 93
“Recovery and/or increase of NAD+ levels can protect skeletal muscle from progressive deterioration (Fletcher et al., 2017), reverse the damage to cerebral energy metabolism, increase the protection against OS (López-Otín et al., 2013; Brown et al., 2014; Verdin, 2015), promote the activity of SIRTs and proteins involv…”
BackgroundInfluentialBanerjee, D., Langberg, K. A., Abbas, S., Odermatt, E., Yerramothu, P., Volaric, M. P., Reidenbach, M. A., Krentz, K. J., Rubinstein, C. D., Brautigan, D. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26240-9 · Cited by 92
The intestinal immune system and gut barrier function in obesity and ageing
Shemtov, S. J., Emani, R., Bielska, O., Covarrubias, A. J., Verdin, E. M., Andersen, J. K., & Winer, D. A. (2022) · FEBS Journal · doi:10.1111/febs.16558 · Cited by 87
Self-citationBerven, H., Kverneng, S. U., Sheard, E., Søgnen, M., Geijerstam, S. A. A., Haugarvoll, K., Skeie, G. O., Dölle, C., & Tzoulis, C. (2023) · Nature Communications · doi:10.1038/s41467-023-43514-6 · Cited by 96
“In this manner, NAD-replenishment may increase neuronal resilience, shielding neurons against multiple forms of disease-associated stress 5,15 .”
BackgroundLynch, M. R., Tran, M. T., & Parikh, S. M. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00263.2017 · Cited by 85
Kreiter, N., Pal, A., Lojewski, X., Corcia, P., Naujock, M., Reinhardt, P., Sterneckert, J. L., Petri, S., Wegner, F., Storch, A., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.010 · Cited by 90
Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets
Wu, L., Xie, X., Liang, T., Ma, J., Yang, L., Yang, J., Li, L., Xi, Y., Li, H., Zhang, J., et al. (2021) · Biomolecules · doi:10.3390/biom12010039 · Cited by 92
Bock, K. W. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114093 · Cited by 93
Yarbro, J. R., Emmons, R. S., & Pence, B. D. (2020) · Immunometabolism · doi:10.20900/immunometab20200026 · Cited by 87
“NAD can be obtained from tryptophan via the de novo biosynthesis pathway, also called the kynurenine pathway (KP), nicotinic acid (NA) through the Preiss-Handler pathway, and recycling from nicotinamide (NAM) via the salvage pathway [143].”
BackgroundCao, J., Zhong, M. B., Toro, C. A., Zhang, L., & Cai, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.016 · Cited by 79
Trisolini, L., Gambacorta, N., Gorgoglione, R., Montaruli, M., Laera, L., Colella, F., Volpicella, M., Grassi, A., & Pierri, C. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122117 · Cited by 82
Metadata
- Authors
- Verdin, E.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Verdin, Eric
- ORCID
- Verdin, Eric
- Venue
- Science
- Published
- 2015-12-04
- Volume
- 350
- Issue
- 6265
- Pages
- 1208-1213
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2284984697
- Cited by
- 1,319
- References
- 116
- Citations by year
- 2026: 177 · 2025: 149 · 2024: 137 · 2023: 120 · 2022: 129 · 2021: 171 · 2020: 123 · 2019: 112 · 2018: 89 · 2017: 70 · 2016: 40 · 2015: 1
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK085610)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- NAD+, aging, metabolism, neurodegeneration, sirtuins, poly(ADP-ribose) polymerase, NAD+ precursors, NAD+ supplementation, healthspan, lifespan, redox reactions, coenzymes
- MeSH terms
- Aging, Diabetes Mellitus, Type 2, DNA Damage, Fatty Liver, Humans, Mitochondria, NAD, Obesity, Oxidation-Reduction, Poly(ADP-ribose) Polymerases, Neurodegenerative Diseases, Sirtuins, Biosynthetic Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.